Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Puerarin for Obesity Treatment
NCT06968208Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Aug 2025
- Primary completion
- Jan 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of puerarin in obesity, sponsored by Ruijin Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
puerarin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06968208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06968208.